about
Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis: a case reportEffects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in ratsInterendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by β(1)-integrinsEffects of Alda-1, an Aldehyde Dehydrogenase-2 Agonist, on Hypoglycemic Neuronal DeathMicroglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation.Cathepsin L acutely alters microvessel integrity within the neurovascular unit during focal cerebral ischemia.Methylmercury Causes Blood-Brain Barrier Damage in Rats via Upregulation of Vascular Endothelial Growth Factor ExpressionMicroglia preconditioned by oxygen-glucose deprivation promote functional recovery in ischemic rats.Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke[Pathognomonic magnetic resonance imaging (MRI) finding of fluid-fluid level in pyogenic ventriculitis: two case reports].Varicella-zoster virus encephalitis localized to the bilateral medial temporal lobes.Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment.Recurrent hypertensive brainstem encephalopathy.An autopsy case of dementia with Lewy bodies showing autonomic failure and dementia as the initial symptoms.Novel locus for benign hereditary chorea with adult onset maps to chromosome 8q21.3 q23.3.Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.Clinical features of patients with myasthenia gravis associated with autoimmune diseases.Microglia and Monocytes/Macrophages Polarization Reveal Novel Therapeutic Mechanism against Stroke.Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study.β1-integrin-matrix interactions modulate cerebral microvessel endothelial cell tight junction expression and permeability.Apparent diffusion coefficient reduction might be a predictor of poor outcome in patients with posterior reversible encephalopathy syndrome.Fluid-fluid levels in lateral ventricles predict bacterial CNS infections.Biochemical and histopathological alterations in TAR DNA-binding protein-43 after acute ischemic stroke in rats.Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke.Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases.Apparent diffusion coefficients distinguish amyotrophic lateral sclerosis from cervical spondylotic myelopathy.A serial MRI study in a patient with progressive supranuclear palsy with cerebellar ataxia.Clinical and imaging findings of progressive supranuclear palsy with predominant cerebellar ataxia.Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imagingChronic myositis with cardiomyopathy and respiratory failure associated with mild form of organ-specific autoimmune diseasesPredictors of outcome in hypoglycemic encephalopathyPredictors of cognitive impairment in multiple system atrophyA novel therapeutic approach using peripheral blood mononuclear cells preconditioned by oxygen-glucose deprivationRole of RNF213 p.4810K variant in the development of intracranial arterial disease in patients treated with nilotinibElevated serum pentraxin 3 levels might predict the diagnosis of branch atheromatous disease at a very early stagePublisher Correction: A novel therapeutic approach using peripheral blood mononuclear cells preconditioned by oxygen-glucose deprivationAngiogenesis in the ischemic core: A potential treatment target?
P50
Q28214132-B172A5B1-9302-4A91-9A06-A11948900451Q33711943-2E419E92-EDDB-4C2F-BD4C-9CFB86B92E33Q35524206-391E950D-2E65-44CA-A71B-976AE8C34236Q35666283-6B34E6F5-4B44-411D-95C4-6ABFF03CD44BQ35939162-D7B6A06C-F22D-41F1-A09C-4C04AD9E6EF0Q36254387-85355A84-A5D7-40F5-BD57-73019A87A702Q36258809-692CCCFC-236E-4BC2-9E22-21918816D797Q37640315-5049D046-B8D3-4D82-850B-A688F8481E1AQ39040401-02D036F8-4F04-4EA7-8D99-4530503F249CQ40188282-D82F7153-0744-416F-9B89-33DB823EC800Q40512847-998BA18E-AC81-48D1-97F0-CE03BD0A068AQ42673977-1F761AA1-3E1F-49C6-856C-C974B2F51125Q43067689-32BD956E-45EB-47D2-9A96-910994965FFFQ43964377-8E81685A-DD3E-4906-A98D-170C1C7BFA8CQ45304765-A4A2EF2E-CBF3-4794-8A22-D0C8F70486D5Q45951185-55565A1B-7E85-4A14-8BC0-98255EC2DE42Q46946195-3CF64F93-81CF-4E48-862B-BDE0257E7207Q47106944-C19C163C-FACD-46EA-A75C-0464DC946504Q47889916-7EAA4668-5063-40A2-B15C-ED485B3F4763Q47978916-262EF1B2-12AB-4A97-9321-6C63C5364F36Q48027691-0916EE87-3ED8-49A5-A1B8-1E082405F0B9Q48100858-0A51D0C1-7960-4B0A-B85C-4600C3D27907Q48161812-9C113DAE-CAB5-4B14-ACA6-728B49B111EEQ48248773-512ED390-1C06-4E6D-B666-0EB4720E91A3Q48292290-C1DE7E12-97BC-4660-9610-2D961D0A844EQ48294327-05315FA8-2CC8-47FA-891D-01EACD8E66B4Q48792754-10CEFBEC-174D-4DC2-80DC-530EAF3942C7Q53133475-6043C13C-88F3-4A34-AE69-D07D8A3B92A5Q80573197-4ABBBF12-2261-47D3-A879-CEB0098F51C2Q80732468-A7630A13-1511-41DF-BF43-126BA29F466BQ87035061-AC80246C-C1DB-4803-9FC4-C5F2D1049122Q88297972-7A41127B-F532-461F-8C93-B2070A4C09A2Q91286955-F57E8429-1D1D-4BDC-B9D3-F363C1E19EF2Q91305750-6462BAA6-DDC1-4869-94D2-54C31C760411Q91588981-63637707-32F8-4B35-95C4-242B17DC86F3Q92163603-7795804E-397B-4709-9FAA-566E9213ADC1Q92174939-D0D0651A-FFC7-4D03-AE84-89C62406D494
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Masato Kanazawa
@ast
Masato Kanazawa
@en
Masato Kanazawa
@es
Masato Kanazawa
@nl
Masato Kanazawa
@sl
type
label
Masato Kanazawa
@ast
Masato Kanazawa
@en
Masato Kanazawa
@es
Masato Kanazawa
@nl
Masato Kanazawa
@sl
prefLabel
Masato Kanazawa
@ast
Masato Kanazawa
@en
Masato Kanazawa
@es
Masato Kanazawa
@nl
Masato Kanazawa
@sl
P1053
J-3267-2017
P106
P1153
7202046999
P21
P31
P3829
P3835
masato-kanazawa
P496
0000-0001-6337-8156